Reveromycin A, the dominant analogue of a complex of spiroketals isolated from a Streptomyces sp., is an inhibitor of the mitogenic activity of EGF. Reveromycin A displays antiproliferative behaviour against human cell lines KB and K562, as well as potent antifungal activity. More recently it has been shown to induce apoptosis in osteoclasts thus inhibiting bone resorption.
Reveromycin A is soluble in ethanol, methanol, DMF and DMSO.
CAS Number
134615-37-5
Molecular Formula
C36H52O11
Molecular Weight
660.8
Mechanism of Action
Reveromycin A is a G1 phase cell cycle inhibitor, selectively inhibiting isoleucyl-tRNA synthetase.
Storage Conditions
-20°C